Bristol-Myers Squibb Company (BMY) · page 156 of 197
The slide uses S-4 filing data to support the activist's argument that the company is fundamentally strong, likely to contrast with a critique of management's execution or capital allocation elsewhere in the deck.
Activist deck · key_takeaways · summarize · dense density
Slide locked Sign in to view
Slide schematic 7/7
chart 2/2 paragraph 1/1 source-note 1/1 table 1/1 title 2/2
Components 7
bar-vertical bar-vertical paragraph source-note data action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.